0001824034-22-000001.txt : 20221027
0001824034-22-000001.hdr.sgml : 20221027
20221027172212
ACCESSION NUMBER: 0001824034-22-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20221027
DATE AS OF CHANGE: 20221027
EFFECTIVENESS DATE: 20221027
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avicenna Biosciences, Inc.
CENTRAL INDEX KEY: 0001824034
IRS NUMBER: 851962440
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-463082
FILM NUMBER: 221338262
BUSINESS ADDRESS:
STREET 1: 701 WEST MAIN STREET, SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27701
BUSINESS PHONE: 919-667-2504
MAIL ADDRESS:
STREET 1: 701 WEST MAIN STREET, SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27701
D
1
primary_doc.xml
X0708
D
LIVE
0001824034
Avicenna Biosciences, Inc.
701 WEST MAIN STREET, SUITE 200
DURHAM
NC
NORTH CAROLINA
27701
919-667-2504
DELAWARE
None
None
Corporation
true
2020
Christopher
Meldrum
c/o Avicenna Biosciences, Inc.
701 West Main Street, Suite 200
Durham
NC
NORTH CAROLINA
27701
Executive Officer
Director
Thomas
Kaiser
c/o Avicenna Biosciences, Inc.
701 West Main Street, Suite 200
Durham
NC
NORTH CAROLINA
27701
Director
Pieter
Burger
c/o Avicenna Biosciences, Inc.
701 West Main Street, Suite 200
Durham
NC
NORTH CAROLINA
27701
Director
John
Hamer
c/o Avicenna Biosciences, Inc.
701 West Main Street, Suite 200
Durham
NC
NORTH CAROLINA
27701
Director
Dennis
Langer
c/o Avicenna Biosciences, Inc.
701 West Main Street, Suite 200
Durham
NC
NORTH CAROLINA
27701
Director
Biotechnology
Decline to Disclose
- 06b
false
2022-02-17
true
true
false
0
18000
18000
0
false
1
0
0
0
Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering.
false
Avicenna Biosciences, Inc.
/s/ Christopher Meldrum
Christopher Meldrum
President
2022-05-11